Anticonvulsant effects of melatonin in amygdala-kindled rats

Neuroscience Letters

Volumn 257, Issue 1, 1998, Pages 13-16

  Mevissen, Meike ^a   Ebert, Ulrich ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Afterdischarge; Diurnal rhythm; Kindling; Seizure threshold; Temporal lobe epilepsy

Indexed keywords

MELATONIN;

AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BODY TEMPERATURE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EPILEPTOGENESIS; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE THRESHOLD; TEMPORAL LOBE EPILEPSY;

AMYGDALA; ANIMALS; ANTICONVULSANTS; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; EPILEPSY; FEMALE; KINDLING, NEUROLOGIC; MELATONIN; RATS; RATS, WISTAR; SEIZURES;

EID: 0032553347     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00790-3     Document Type: Article

References (30)

1. Acuna-Castroviejo D., Escames G., Macias M., Munoz-Hoyos A., Molina-Carballo A., Arauzo M., Montes R. Cell protective role of melatonin in the brain. J. Pineal Res. 19:1995;57-63.
2. Albertson T.E., Peterson S.L., Stark L.G., Lakin M.L., Winters W.D. The anticonvulsant properties of melatonin in kindled seizures in rats. Neuropharmacology. 20:1981;61-66.
3. Bartness T.J., Powers J.B., Hastings M.H., Bittman E.L., Goldman B.D. The timed infusion paradigm for melatonin delivery: what has it taught us about the melatonin signal, its reception, and the photoperiodic control of seasonal responses. J. Pineal Res. 15:1993;161-190.
4. Champney T.H., Champney J.A. Novel anticonvulsant action of chronic melatonin in gerbils. NeuroReport. 3:1992;1152-1154.
5. Champney T.H., Hanneman W.H., Legare M.E., Appel K. Acute and chronic effects of melatonin as an anticonvulsant in male gerbils. J. Pineal Res. 20:1996;79-83.
6. Champney, T.H. and Peterson, S.L., Circadian, seasonal, pineal, and melatonin influences on epilepsy. In H.-S. Yu and R.J. Reiter (Eds.), Melatonin: Biosynthesis, Physiological Effects, and Clinical Applications, CRC Press, Boca Raton, FL, 1993, pp. 477-494.
7. Ebert U., Cramer S., Löscher W. Phenytoin's effect on the spread of seizure activity in the amygdala kindling model. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;341-347.
8. Ebert U., Rundfeldt C., Löscher W. Development and pharmacological suppression of secondary afterdischarges in the hippocampus of amygdala-kindled rats. Eur. J. Neurosci. 7:1995;732-741.
9. B receptor antagonist and a polyamine site antagonist in amygdala-kindled rats. Eur. J. Pharmacol. 322:1997;179-184.
10. Giusti P., Gusella M., Lipartiti M., Milani D., Zhu W., Vicini S., Manev H. Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity. Exp. Neurol. 131:1995;39-46.
11. Golombek D.A., Fernandez-Duque D., DeBrito-Sanchez M.G., Burin L., Cardinali D.P. Time-dependent anticonvulsant activity of melatonin in hamsters. Eur. J. Pharmacol. 210:1992;253-258.
12. Hauser W.A., Annegers J.F., Kurland T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 34:1993;453-468.
13. Lipartiti M., Franceschini D., Zanoni R., Gusella M., Giusti P., Cagnoli C.M., Kharlamov A., Manev H. Neuroprotective effects of melatonin. Adv. Exp. Med. Biol. 398:1996;315-321.
14. Löscher W., Ebert U. Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy. Epilepsy Res. Suppl. 11:1996;17-43.
15. Löscher W., Ebert U., Wahnschaffe U., Rundfeldt C. Susceptibility of different cell layers of the anterior and posterior part of the piriform cortex to electrical stimulation and kindling: comparison with the basolateral amygdala and 'area tempestas'. Neuroscience. 66:1995;265-276.
16. Löscher W., Fiedler M. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VI. Seasonal influences on maximal electroshock and pentylenetetrazol seizure thresholds. Epilepsy Res. 25:1996;3-10.
17. Löscher W., Hönack D. Anticonvulsant and behavioural effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J. Pharmacol. Exp. Ther. 256:1991;432-440.
18. Löscher W., Rundfeldt C., Hönack D. Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. Epilepsy Res. 9:1993;11-18.
19. Löscher W., Rundfeldt C., Hönack D. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Eur. J. Neurosci. 5:1993;1545-1550.
20. Löscher W., Schmidt D. Which animal models should be used in the search of new antiepileptic drugs? A proposal based on experimental and clinical observations. Epilepsy Res. 2:1988;145-181.
21. Löscher W., Wahnschaffe U., Mevissen M., Lerchl A., Stamm A. Effects of weak alternating magnetic fields on nocturnal melatonin production and mammary carcinogenesis in rats. Oncology. 51:1994;288-295.
22. Manev H., Uz T., Kharlamov A., Cagnoli C.M., Franceschini D., Giusti P. In vivo protection against kainate-induced apoptosis by the pineal hormone melatonin: effect of exogenous melatonin and circadian rhythm. Restorat. Neurol. Neurosci. 9:1996;251-256.
23. Molina-Carballo A., Munoz-Hoyos A., Reiter R.J., Sanchez-Forte M., Moreno-Madrid F., Rufo-Campos M., Molina-Font J.A., Acuna-Castroviejo D. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years experience. J. Pineal Res. 23:1997;97-105.
24. Murakami M., Greer M.A., Lewy A.J., Greer S.E., McAdams S. Ontogenesis of pineal thyroxine 5′-deiodase activity and plasma melatonin concentration in the rat. Neuroendocrinology. 50:1989;476-480.
25. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Sydney, 1986.
26. Racine R. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroenceph. clin. Neurophysiol. 32:1972;281-294.
27. Reiter R.J., Melchiorri D., Sewerynek E., Poeggeler B., Barlow-Walden L., Chuang J., Ortiz G.G., Acuno-Castroviejo D. A review of the evidence supporting melatonin's role as an anticonvulsant. J. Pineal Res. 18:1995;1-11.
28. Sugden D.J. Psychopharmacological effects of melatonin in mouse and rats. Pharmacol. Exp. Ther. 227:1983;587-591.
29. Uz T., Giusti P., Franceschini D., Kharlamov A., Manev H. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neuroscience. 73:1996;631-636.
30. Weiss G., Lucero K., Fernandez M. The effect of adrenalectomy on the circadian variation in the rate of kindled seizure development. Brain Res. 612:1993;354-356.